Kaiser Bottom Fish OnlineFree trialNew StuffHow It WorksContact UsTerms of UseHome
Specializing in Canadian Stocks
SearchAdvanced Search
Welcome Guest User   (more...)
Home / Research Tools
Research Tools
 Corporate Profile: Emerald Resources NL
    Publisher: Kaiser Research Online
    Author: Copyright 2017 John A. Kaiser
 
Emerald Resources NL (EMR-ASX)
Trade DateVolumeHighLowCloseChgStatus
April 18, 20243,073,635$3.82$3.54$3.76$0.15Trading
KRO Profile - Members OnlyCorporate Web Site Not AvailableTreeExchQuote
Issued
595,461,968		 Price
$3.760		 Working Capital
$29,547,000		 Key People: Morgan C. Hart (MD), Simon Lee (Chair), Mark Clements (Sec),
Diluted
612,036,968		 Insiders
141.6%		 As of
6/30/2023
Company supplied Corporate Overview - not available
The free corporate profile serves as a fast gateway for KRO members via the map cards to resources such as the KRO Profile which includes financial, insider and project details as well as news releases and KRO comments for which headline links are provided below. Links to the company's web site and project web pages are available within this free corporate profile if the company has a multi-user corporate membership (they are always available in full member only KRO Profile). A corporate membership provides the company with complete multiple user access to KRO resources and entitles the company to provide a corporate overview for the subject company's unrestricted corporate profile.

Active Project List
ProjectCountryState/ProvRegionNet
Interest		StageIPV $
MM		Target MetalsDeposit StyleTSC
(Project Name has a link to its location in the Members only KRO Profile)
OkvauCambodiaOtherNot Applicable100% WI7-Permitting & Feasibility $2,209GoldIntrusive-Related Veins
Company Project Gateway
Okvau Project
Company Project Web Page - N/A Cambodia - Other 100% WI7-Permitting & Feasibility GoldIntrusive-Related Veins
Company News Releases - Members Only
Apr 18, 2024Significant Exploration Results Continue at Emerald Projects
Apr 15, 2024Fifth Supplementary Bidder's Statement
Apr 12, 2024Recommended and Unconditional Takeover Offer Best and Final
Apr 10, 2024Application for quotation of securities - EMR
Apr 10, 2024Option Exercise
Apr 10, 2024Application for quotation of securities - EMR
Apr 10, 2024Fourth Supplementary Bidder's Statement
Apr 9, 2024Fourth Supplementary Target's Statement
Apr 8, 2024Okvau Continues to Deliver - Quarterly Gold Production
Apr 5, 2024Recommended and Unconditional Takeover Offer Extended
Mar 26, 2024Notification regarding unquoted securities - EMR
Mar 21, 2024Third Supplementary Target's Statement
Mar 20, 2024Change in substantial holding
Mar 20, 2024Third Supplementary Bidder's Statement
Mar 18, 2024New High Grade Gold Discovery - Freeman's Find Prospect
Mar 15, 2024Recommended and Unconditional Takeover Offer Extended
Mar 12, 2024Application for quotation of securities - EMR
Mar 12, 2024Option Exercise
Mar 4, 2024Change in substantial holding
Mar 4, 2024Notification regarding unquoted securities - EMR
Mar 4, 2024Proposed issue of securities - EMR
Mar 4, 2024Change in substantial holding
Mar 1, 2024Board and Sub-Committee Changes
Mar 1, 2024Final Director's Interest Notice
Feb 29, 2024Emerald's Growth Strategy Underpinned by Okvau Excellence
Feb 29, 2024Half Yearly Report and Accounts
Feb 20, 2024Recommended and Unconditional Takeover Offer Extended
Feb 15, 2024Second Supplementary Target's Statement
Feb 9, 2024Application for quotation of securities - EMR
Feb 9, 2024Application for quotation of securities - EMR
Feb 9, 2024Option Exercise
Feb 1, 2024Option Exercise
Feb 1, 2024Application for quotation of securities - EMR
Jan 30, 2024Quarterly Report
Jan 25, 2024Recommended and Unconditional Takeover Offer Extended
Jan 24, 2024Significant Exploration Results Continue at EMR Prospects
Jan 12, 2024Application for quotation of securities - EMR
Jan 5, 2024Application for quotation of securities - EMR
Dec 29, 2023Recommended and Unconditional Takeover Offer Extended
Dec 29, 2023Application for quotation of securities - EMR
Dec 22, 2023Application for quotation of securities - EMR
Dec 21, 2023Maiden Memot Gold Project Resource Statement
Dec 18, 2023Option Exercise
Dec 18, 2023Application for quotation of securities - EMR
Dec 18, 2023Application for quotation of securities - EMR
Dec 12, 2023Modern Slavery Statement
Dec 8, 2023Application for quotation of securities - EMR
Dec 7, 2023Change in substantial holding
Dec 1, 2023Application for quotation of securities - EMR
Dec 1, 2023Option Exercise
Dec 1, 2023Application for quotation of securities - EMR
Dec 1, 2023Change of Director's Interest Notice
Dec 1, 2023Notification regarding unquoted securities - EMR
Nov 29, 2023Annual General Meeting Presentation
Nov 29, 2023Chairman's Address - 2023 Annual General Meeting
Nov 29, 2023Results of Annual General Meeting
Nov 24, 2023Application for quotation of securities - EMR
Nov 24, 2023Option Exercise
Nov 24, 2023Recommended and Unconditional Takeover Offer Extended
Nov 14, 2023Application for quotation of securities - EMR
Nov 14, 2023Option Exercise
Nov 13, 2023Application for quotation of securities - EMR
Nov 9, 2023Supplementary Target's Statement
Nov 1, 2023Second Supplementary Bidder's Statement
Nov 1, 2023Application for quotation of securities - EMR
Nov 1, 2023Option Exercise
Oct 31, 2023Quarterly Report
Oct 31, 2023InvoCare Limited to be removed from the S&P/ASX 200 Index
Oct 30, 2023Significant Exploration Results Continue at EMR Prospects
Oct 27, 2023Recommended and Unconditional Takeover Offer Extended
Oct 26, 2023Annual Report to shareholders
Oct 26, 2023Letter to Shareholders - AGM Materials
Oct 26, 2023Notice of Annual General Meeting/Proxy Form
Oct 13, 2023Application for quotation of securities - EMR
Oct 13, 2023Emerald Moves to 76.5% of Bullseye
Oct 9, 2023Recommended and Unconditional Takeover Offer for Bullseye
Oct 9, 2023EMR Continues to Meet Guidance - Quarterly Gold Production
Oct 5, 2023Date of Annual General Meeting
Oct 2, 2023Notification regarding unquoted securities - EMR
Oct 2, 2023ESOP Option Issue
Oct 2, 2023Proposed issue of securities - EMR
Sep 21, 2023Recommended and Unconditional Takeover Offer Extended
Sep 14, 2023Recommended Takeover Offer for Bullseye Mining Unconditional
Sep 7, 2023Change in substantial holding
Sep 6, 2023Application for quotation of securities - EMR
Sep 6, 2023Option Exercise
Sep 6, 2023Target's Statement
Sep 4, 2023Supplementary Bidder's Statement
Sep 1, 2023S&P DJI Announces September 2023 Quarterly Rebalance

 
 

You can return to the Top of this page


Copyright © 2024 Kaiser Research Online, All Rights Reserved